NEW YORK, Oct. 3 – Microarray technology developer Nanogen said Wednesday that it had sold seven of its NanoChip Molecular Biology Workstations during the quarter and placed another three through non-title transfer agreements to development site partners.

Nanogen said that it has placed 40 of its SNP scoring workstations to unnamed customers and collaborators.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.